Insider Transactions in Q1 2025 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 14
2025
|
Tushar Bhikhubhai Patel |
SELL
Open market or private sale
|
Indirect |
5,000,000
-9.33%
|
$40,000,000
$8.35 P/Share
|
Mar 10
2025
|
J Kevin Buchi Director |
SELL
Bona fide gift
|
Direct |
262,072
-100.0%
|
-
|
Mar 06
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
46,936
-59.01%
|
$375,488
$8.73 P/Share
|
Mar 05
2025
|
Emily Peterson Alva Director |
SELL
Open market or private sale
|
Direct |
80,000
-31.9%
|
$640,000
$8.9 P/Share
|
Mar 05
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-13.85%
|
$800,000
$8.91 P/Share
|
Mar 05
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
43,064
-35.12%
|
$344,512
$8.88 P/Share
|
Mar 05
2025
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
125,000
-30.11%
|
$1,000,000
$8.89 P/Share
|
Mar 04
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,579
-11.27%
|
$124,632
$8.84 P/Share
|
Mar 04
2025
|
Jason B. Daly EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,879
+20.61%
|
-
|
Mar 04
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
19,537
-4.5%
|
$156,296
$8.84 P/Share
|
Mar 04
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
38,194
+8.08%
|
-
|
Mar 04
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,497
-3.02%
|
$179,976
$8.84 P/Share
|
Mar 04
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,981
+5.58%
|
-
|
Mar 04
2025
|
Chintu Patel Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
46,528
-5.11%
|
$372,224
$8.84 P/Share
|
Mar 04
2025
|
Chintu Patel Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
92,592
+9.23%
|
-
|
Mar 04
2025
|
Chirag K. Patel President & Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
47,361
-5.23%
|
$378,888
$8.84 P/Share
|
Mar 04
2025
|
Chirag K. Patel President & Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
92,592
+9.28%
|
-
|
Mar 04
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,353
-4.02%
|
$146,824
$8.84 P/Share
|
Mar 04
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,879
+7.29%
|
-
|
Mar 03
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,145
-24.75%
|
$393,160
$8.76 P/Share
|
Mar 03
2025
|
Jason B. Daly EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
151,451
+43.96%
|
-
|
Mar 03
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
125,805
-10.19%
|
$1,006,440
$8.76 P/Share
|
Mar 03
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
245,950
+16.14%
|
-
|
Mar 03
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
133,410
-6.09%
|
$1,067,280
$8.76 P/Share
|
Mar 03
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
283,789
+11.31%
|
-
|
Mar 03
2025
|
Chintu Patel Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
274,307
-25.11%
|
$2,194,456
$8.76 P/Share
|
Mar 03
2025
|
Chintu Patel Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
579,710
+34.67%
|
-
|
Mar 03
2025
|
Chirag K. Patel President & Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
279,527
-25.59%
|
$2,236,216
$8.76 P/Share
|
Mar 03
2025
|
Chirag K. Patel President & Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
579,710
+34.67%
|
-
|
Mar 03
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
116,128
-8.88%
|
$929,024
$8.76 P/Share
|
Mar 03
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
227,032
+14.36%
|
-
|
Mar 03
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
80,000
-4.24%
|
$640,000
$8.9 P/Share
|
Mar 01
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,737
-4.07%
|
$93,896
$8.67 P/Share
|
Mar 01
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,371
+9.82%
|
-
|
Mar 01
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,985
-3.43%
|
$87,880
$8.67 P/Share
|
Mar 01
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,958
+8.28%
|
-
|
Mar 01
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,494
-2.39%
|
$107,952
$8.67 P/Share
|
Mar 01
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,197
+6.04%
|
-
|
Feb 03
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
80,000
-4.06%
|
$640,000
$8.14 P/Share
|
Jan 08
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
62,590
-3.08%
|
$500,720
$8.01 P/Share
|
Jan 02
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
17,410
-0.85%
|
$139,280
$8.01 P/Share
|